|
Relationship between EphA7 expression or microvessel count and clinicopathological features of 32 patients with GBM. |
||||||
| EphA7 expression |
P value |
MVD |
P value |
|||
|
|
||||||
| Age |
N |
positive (%) |
N |
high MVD N (%) |
||
| <= 50 |
10 |
3 (30) |
11 |
6 (54.55) |
||
| >50 |
22 |
19 (86.36) |
0.003 |
21 |
16 (76.19) |
ns |
| Gender |
||||||
| male |
21 |
15 (71.43) |
21 |
15 (71.43) |
||
| female |
11 |
7 (63.64) |
ns |
11 |
8 (72.72) |
ns |
| Tumor status |
||||||
| Primary |
26 |
20 (76.92) |
26 |
22 (84.62) |
||
| Recurrence |
6 |
2 (33.33) |
ns |
6 |
1 (16.67) |
0.003 |
|
MVD: microvessel density, N: number of patients, ns: not significant. The median MVD of 30 vessels was used as a cutpoint. | ||||||
Wang et al. BMC Cancer 2008 8:79 doi:10.1186/1471-2407-8-79 |
||||||